If you are having trouble viewing this message, please view it in your web browser.
|
|
2024 Issue 3
|
|
In Silico Data as a Basis for Supporting or Denying Patentability in Korea
|
In silico (i.e., computer simulation-based) research techniques are being increasingly utilized in new drug development, aided by advancements in computing power and technologies. Consequently, the extent to which in silico data can be relied upon to support a pharmaceutical invention has increasingly been the subject of debate.
|
Read more
|
|
|
TRADEMARK, DESIGN & UNFAIR COMPETITION |
|
|
|
|
|
|
|
|
|
|
|
This legal update is provided for general informational purposes only and should not be considered a legal opinion of KIM & CHANG nor relied upon in lieu of specific advice. Recipients of this publication, whether clients or otherwise, should not act
or refrain from acting on the basis of any information included in this publication without seeking appropriate legal or other professional advice.
For more newsletters and legal updates of KIM & CHANG, please visit our website - www.kimchang.com or www.ip.kimchang.com
[UNSUBSCRIBE]
If you do not wish to receive our e-mail service, please click here.
|
|
|
© 2024 Kim & Chang |
|
|